| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer.
|
Nat Med
|
2004
|
2.11
|
|
2
|
Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells.
|
Cancer Res
|
2003
|
1.46
|
|
3
|
E-cadherin controls beta-catenin and NF-kappaB transcriptional activity in mesenchymal gene expression.
|
J Cell Sci
|
2008
|
1.44
|
|
4
|
The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells.
|
Carcinogenesis
|
2007
|
1.27
|
|
5
|
Vitamin D and colon cancer.
|
Endocr Relat Cancer
|
2012
|
1.20
|
|
6
|
KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells.
|
Hum Mol Genet
|
2011
|
1.10
|
|
7
|
RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells.
|
J Cell Biol
|
2008
|
1.01
|
|
8
|
Vitamin D has wide regulatory effects on histone demethylase genes.
|
Cell Cycle
|
2012
|
0.99
|
|
9
|
Effects of 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells.
|
Anticancer Res
|
2006
|
0.92
|
|
10
|
Site-dependent E-cadherin cleavage and nuclear translocation in a metastatic colorectal cancer model.
|
Am J Pathol
|
2010
|
0.85
|
|
11
|
Vitamin D: Proteases, protease inhibitors and cancer.
|
Cell Cycle
|
2010
|
0.83
|
|
12
|
The effects of 1,25-dihydroxyvitamin D3 on colon cancer cells depend on RhoA-ROCK-p38MAPK-MSK signaling.
|
J Steroid Biochem Mol Biol
|
2010
|
0.82
|
|
13
|
Proteomic analysis of 1α,25-dihydroxyvitamin D3 action on human colon cancer cells reveals a link to splicing regulation.
|
J Proteomics
|
2011
|
0.80
|
|
14
|
Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D₃ analogues with a long side chain at C12 and short C17 side chains.
|
J Med Chem
|
2012
|
0.78
|
|
15
|
Synthesis, structure, and biological activity of des-side chain analogues of 1α,25-dihydroxyvitamin D3 with substituents at C18.
|
ChemMedChem
|
2011
|
0.76
|
|
16
|
The first locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D3) induce vitamin D receptor transcriptional activity.
|
Org Lett
|
2003
|
0.75
|